The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries
Open accessAbstract
Vaccine hesitancy forms a critical barrier to the uptake of COVID-19 vaccine in high-income countries or regions. This review aims to summarize rates of COVID-19 hesitancy and its determinants in high-income countries or regions. A scoping review was conducted in Medline®, Embase®, CINAHL®, and Scopus® and was reported in accordance with the PRISMA-SCr checklist. The search was current as of March 2021. Studies which evaluated COVID-19 vaccine hesitancy and its determinants in high-income countries (US$12,536 or more GNI per capita in 2019) were included. Studies conducted in low, lower-middle, and upper-middle income countries or regions were excluded. Factors associated with vaccine hesitancy were grouped into four themes (vaccine specific, individual, group, or contextual related factors). Of 2237 articles retrieved, 97 articles were included in this review. Most studies were conducted in U.S. (n = 39) and Italy (n = 9). The rates of vaccine hesitancy across high-income countries or regions ranged from 7–77.9%. 46 studies (47.4%) had rates of 30% and more. Younger age, females, not being of white ethnicity and lower education were common contextual factors associated with increased vaccine hesitancy. Lack of recent history of influenza vaccination, lower self-perceived risk of contracting COVID-19, lesser fear of COVID-19, believing that COVID-19 is not severe and not having chronic medical conditions were most frequently studied individual/group factors associated with increased vaccine hesitancy. Common vaccine-specific factors associated with increased vaccine hesitancy included beliefs that vaccine are not safe/effective and increased concerns about rapid development of COVID-19 vaccines. Given the heterogeneity in vaccine hesitancy definitions used across studies, there is a need for standardization in its assessment. This review has summarized COVID-19 vaccine hesitancy determinants that national policymakers can use when formulating health policies related to COVID-19 vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Eysenbach, G. (2004) · Journal of Medical Internet Research · doi:10.2196/jmir.6.3.e34 · Cited by 6,480
Wright, K. B. (2006) · Journal of Computer-Mediated Communication · doi:10.1111/j.1083-6101.2005.tb00259.x · Cited by 2,550
Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D., & Paterson, P. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.081 · Cited by 2,254 · cited 1×
“The determinants of vaccine related hesitancy were grouped into three main categories: contextual influences, individual/group influences, and vaccine/vaccination specific issues, as proposed by the Strategic Advisory Group of Experts (SAGE) on immunization [6,17].”
BackgroundCOVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128
A global database of COVID-19 vaccinations
Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C., & Rodés-Guirao, L. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01122-8 · Cited by 1,974
Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA
Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K., & Larson, H. J. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01056-1 · Cited by 1,800
Vaccine hesitancy: the next challenge in the fight against COVID-19
Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00671-y · Cited by 1,714
Determinants of COVID-19 vaccine acceptance in the US
Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100495 · Cited by 1,540
Wouters, O. J., Shadlen, K. C., Salcher-Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00306-8 · Cited by 1,288
Cited by
Larson, H. J., Gakidou, E., & Murray, C. J. L. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2106441 · Cited by 510
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Rabin, K., Ratzan, S. C., Parsons Leigh, J., Hu, J., & El-Mohandes, A. (2022) · Nature Communications · doi:10.1038/s41467-022-31441-x · Cited by 449
Cénat, J. M., Noorishad, P.-G., Bakombo, S. M., Onesi, O., Mesbahi, A., Darius, W. P., Caulley, L., Yaya, S., Chomienne, M.-H., Etowa, J., et al. (2022) · Vaccines · doi:10.3390/vaccines10111937 · Cited by 41
Aitken, Z., Emerson, E., & Kavanagh, A. M. (2023) · Health Promotion Journal of Australia · doi:10.1002/hpja.691 · Cited by 9
Metadata
- Authors
- Aw, J., Seng, J. J. B., Seah, S. S. Y., & Low, L. L.
- Venue
- Vaccines
- Publisher
- MDPI AG
- Published
- 2021-08-13
- Volume
- 9
- Issue
- 8
- Pages
- 900
- ISSN
- 2076-393X (ISSN-L)
- OpenAlex
- W3194066091
- Cited by
- 421
- References
- 116
- FWCI
- 48.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries. https://app.cochat.ai/papers/10.3390/vaccines9080900
- The paper
- Aw, J., Seng, J. J. B., Seah, S. S. Y., & Low, L. L. (2021). COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries. Vaccines. https://doi.org/10.3390/vaccines9080900
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.